BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2656908)

  • 1. Quantitation of hepatitis B viral DNA by solution hybridization: comparison with DNA polymerase and hepatitis B e antigen during antiviral therapy.
    Kuhns MC; McNamara AL; Perrillo RP; Cabal CM; Campbel CR
    J Med Virol; 1989 Apr; 27(4):274-81. PubMed ID: 2656908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
    Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon.
    Carreño V; Porres JC; Mora I; Bartolomé J; Bas C; Gutiez J; Cortés J; Hernández Guio C
    Liver; 1987 Dec; 7(6):325-32. PubMed ID: 3437794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of hepatitis B virus (HBV) core antigen in serum in the presence of antibodies to HBV core antigen: comparison with assays of serum HBV DNA, DNA polymerase, and HBV e antigen.
    Bredehorst R; von Wulffen H; Granato C
    J Clin Microbiol; 1985 Apr; 21(4):593-8. PubMed ID: 3988901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.
    Takkenberg B; Terpstra V; Zaaijer H; Weegink C; Dijkgraaf M; Jansen P; Beld M; Reesink H
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1527-35. PubMed ID: 21557773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B.
    Heijtink RA; Kruining J; Honkoop P; Kuhns MC; Hop WC; Osterhaus AD; Schalm SW
    J Med Virol; 1997 Nov; 53(3):282-7. PubMed ID: 9365897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of ARA-AMP on serum DNA polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection. A possible reason for lack of efficacy.
    Alexander GJ; Fagan EA; Rolando N; Guarner P; Callender ME; Eddleston AL; Williams R
    J Hepatol; 1986; 3 Suppl 2():S81-6. PubMed ID: 2439580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of antiviral therapy with quantitative evaluation of HBeAg: a comparison with HBV DNA testing.
    Perrillo R; Mimms L; Schechtman K; Robbins D; Campbell C
    Hepatology; 1993 Dec; 18(6):1306-12. PubMed ID: 8244253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
    Sonneveld MJ; Rijckborst V; Cakaloglu Y; Simon K; Heathcote EJ; Tabak F; Mach T; Boucher CA; Hansen BE; Zeuzem S; Janssen HL
    Antivir Ther; 2012; 17(1):9-17. PubMed ID: 22267464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis B virus DNA as a marker of viral multiplication: comparison with HBe antigen and anti-HBe antibody].
    Thiers V; Bouchardeau F; Courouce AM; Tiollais P; Brechot C
    Presse Med; 1986 Jun; 15(26):1219-22. PubMed ID: 2944091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
    Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
    World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B.
    Lau GK; Cooksley H; Ribeiro RM; Powers KA; Shudo E; Bowden S; Hui CK; Anderson J; Sorbel J; Mondou E; Rousseau F; Lewin S; Perelson AS; Locornini S; Naoumov NV
    Antivir Ther; 2007; 12(5):705-18. PubMed ID: 17713154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus DNA polymerase activity and hepatitis B e antigen (HBeAg)/anti-HBe status among type B chronic liver diseases.
    Kashiwagi S; Hayashi J; Ikematsu H; Nomura H; Kajiyama W; Shingu T; Hayashida K; Kaji M
    Gastroenterol Jpn; 1988 Apr; 23(2):117-23. PubMed ID: 3384275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a quantitative standardized HBV-DNA assay and a classical spot hybridization test in chronic active hepatitis B patients undergoing antiviral therapy.
    Zarski JP; Kuhns M; Berck L; Degos F; Schalm SW; Tiollais P; Bréchot C
    Res Virol; 1989; 140(4):283-91. PubMed ID: 2772413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels.
    Rijckborst V; Hansen BE; Cakaloglu Y; Ferenci P; Tabak F; Akdogan M; Simon K; Akarca US; Flisiak R; Verhey E; Van Vuuren AJ; Boucher CA; ter Borg MJ; Janssen HL
    Hepatology; 2010 Aug; 52(2):454-61. PubMed ID: 20683945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
    Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
    Korenman J; Baker B; Waggoner J; Everhart JE; Di Bisceglie AM; Hoofnagle JH
    Ann Intern Med; 1991 Apr; 114(8):629-34. PubMed ID: 2003708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B.
    Lee SD; Tong MJ; Wu JC; Lin HC; Tsai YT; Lo KJ
    J Hepatol; 1991 Mar; 12(2):246-50. PubMed ID: 2051004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.